LEADER 01406nam  2200433   450 
001 9910134799103321
005 20231006191650.0
010   $a1-119-96948-4
035   $a(CKB)3860000000009941
035   $a(NjHacI)993860000000009941
035   $a(EXLCZ)993860000000009941
100   $a20231006d2012      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aCochrane clinical answers /$fCochrane Innovations and John Wiley & Sons, Ltd
210  1$aNew York :$cJohn Wiley & Sons, Inc.,$d2012.
215   $a1 online resource
330   $aProvides a readable, digestible, clinically focused entry point to rigorous research from Cochrane systematic reviews.
517 3 $aClinical answers
517 3 $aCCAs
606   $aClinical trials
606   $aEvidence-based medicine
606   $aEvidence-Based Medicine$vFull-text
606   $aRandomized Controlled Trials as Topic
615  0$aClinical trials.
615  0$aEvidence-based medicine.
615 12$aEvidence-Based Medicine
615 22$aRandomized Controlled Trials as Topic.
676   $a610.724
712 02$aCochrane Innovations,
712 02$aJohn Wiley & Sons, Ltd,
801  0$bNjHacI
801  1$bNjHacl
912   $a9910134799103321
996   $aCochrane clinical answers$91904754
997   $aUNINA